NCT01443026View on ClinicalTrials.gov

The Effects of Lycopene on High Risk Prostatic Tissue

PHASE2CompletedINTERVENTIONAL
Enrollment

66

Participants

Timeline

Start Date

February 28, 2006

Primary Completion Date

April 30, 2009

Study Completion Date

April 30, 2009

Conditions
Intraepithelial Prostatic NeoplasiaProstatic Neoplasms
Interventions
DRUG

Lycopene 30mg

Lycopene 30 mg.

DRUG

Placebo

Placebo

Trial Locations (2)

60611

Northwestern Memorial Hospital, Chicago

60612

Jesse Brown VA Medical Center, Chicago

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

University of Illinois at Chicago

OTHER

NCT01443026 - The Effects of Lycopene on High Risk Prostatic Tissue | Biotech Hunter | Biotech Hunter